The levels of lipids, lipoproteins and apolipoproteins in healthy people in the central region of the Black Sea

Japanese Heart Journal

Volumn 40, Issue 4, 1999, Pages 427-434

  Adam, Bahattin ^a,b   Talu, Cengiz ^a   Bedir, Abdulkerim ^a   Alvur, Muhlise ^a   Saǧkan, Olcay ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

Author keywords

Apolipoprotein; Lipid; Lipoprotein

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIET; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; RISK FACTOR; SPECTROPHOTOMETRY; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; APOLIPOPROTEINS E; BLOOD PRESSURE; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; TURKEY;

EID: 0032824730     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.40.427     Document Type: Article

References (32)

1. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89: 1329.
2. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823.
3. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987; 257: 2176.
4. Connelly PW, Maclean DR, Horlick L, O'Connor B, Petrasovits A, Little A, Canadian Heart Health Surveys Research Group. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. CMAJ 1992; 146: 1977.
5. Ettinger WH, Wahl PW, Kuller LH, et al. Lipoprotein lipids in older people: result from the Cardiovascular Health Study. Circulation 1992; 86: 858.
6. Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease and death: the Framingham study. Arch Intern Med 1981; 141: 1128.
7. Wilson PWF, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterol. Am J Cardiol 1980; 46: 649.
8. Grundy SM. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin Chem 1995; 41: 139.
9. Willelms JP, Saunders JT, Hunt DE, Schorling JB. Prevalence of coronary heart disease risk factors among rural blacks: a community-based study. South Med J 1997; 90: 814.
10. Barter PJ, Rye K-A. High-density lipoproteins and coronary heart disease. Atherosclerosis 1996; 121: 1.
11. Watkins LO, Neaton JD, Kuller LH. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol 1986; 57: 538.
12. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8.
13. Tervahauta M, Pekkanen J, Kivinen P, et al. Prevalence of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries Study. Atherosclerosis 1993; 104: 47.
14. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo Bon G, Qunici GB. Lipoprotein (a) and the risk for myocardial infarction. Atherosclerosis 1981; 38: 51.
15. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein (a), plasma lipids and other lipoprotein with coronary artery disease documented by angiography. Circulation 1986; 74: 758.
16. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men. BJM 1990; 301: 1248.
17. Genest J Jr, McNamara JR, Ordovas JM, et al. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992; 19: 792.
18. Jauhiainen M, Koskinen P, Ehnholm C, et al. Lipoprotein[a] and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59.
19. Maciejko JJ, Holmes RD, Kottke AB, et al. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med. 1983; 309: 385.
20. Vergani C, Trovato G, Dioguardi N. Serum total lipid, lipoprotein cholesterol, apoprotein A and B in cardiovascular disease. Clin Chim Acta 1978; 87: 127.
21. Eto M, Watanabe K, Iwashima Y, et al. Apolipoprotein E polymorphism, and hyperlipidemia in type II diabetics. Diabetes 1986; 35: 1374.
22. Mahley RW, Palaoǧlu EK, Atak Z, et al. Turkish heart study: lipids, lipoproteins and apolipoproteins. J Lipid Res 1995; 36: 839.
23. Onat A, Şurdum-Avci G, Şenocak M, Örnek E, Gözükam Y. Plasma lipids and their interrelationship in Turkish adults. J Epidemiology Community Health 1992; 46: 470.
24. Friedwald WT, Levy RI and Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499.
25. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease, (the PROCAM experience) Am J Cardiol 1992; 70: 733.
26. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993; 269: 3002.
27. Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex and menopausal status on plasma lipoprotein(a) levels: The Framingham Offspring Study. Circulation 1993; 87: 1135.
28. Fong PC, Tam SC, Tai Y, Lau C, Lee J, Sha Y. Serum lipid and apolipoprotein distributions in Hong Kong Chinese. J Epidemiol Community Health 1994; 48: 356.
29. Leino A, Impivaara O, Kaitsaari M, Jarvisalo J. Serum concentrations of apolipoprotein A-I, apolipoprotein B and lipoprotein(a) in a population sample. Clin Chem 1995; 41: 1633.
30. Noma A, Hata Y, Goto Y. Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III ve E in healthy Japanese by turbidimetric immunoassay: reference values and age-and sex-related differences. Clinica Chimica Acta 1991; 199: 147.
31. Contois JH, McNamara JR, Lammi-Keefe CJ, et al. Reference intervals for plasma apolipoprotein B determined with a standardised commercial immunoturbidimetric assay: result from the Framingham Offspring Study. Clin Chem 1996; 42: 515.
32. Zunic G, Jelic-Ivanovic Z, Spasic S, Stojiljkovic A, Majkic-Singh N. Reference values for apolipoproteins A-I and B in healthy subjects by age. Clin Chem 1992; 38: 566.